ALIVUS LIFE SCIENCES
Back to Balance Sheet
|
ALIVUS LIFE SCIENCES Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹470 Cr | ₹439 Cr | ₹1,015 Cr | ₹747 Cr | ₹1,445 Cr |
What is the latest Total Current Liabilities ratio of ALIVUS LIFE SCIENCES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹470 Cr |
| Mar2024 | ₹439 Cr |
| Mar2023 | ₹1,015 Cr |
| Mar2022 | ₹747 Cr |
| Mar2021 | ₹1,445 Cr |
How is Total Current Liabilities of ALIVUS LIFE SCIENCES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹470 Cr | 7.15 | |
| Mar2024 | ₹439 Cr | -56.77 | |
| Mar2023 | ₹1,015 Cr | 35.90 | |
| Mar2022 | ₹747 Cr | -48.32 | |
| Mar2021 | ₹1,445 Cr | - | |
Compare Total Current Liabilities of peers of ALIVUS LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALIVUS LIFE SCIENCES | ₹10,789.6 Cr | -2.2% | -1.4% | -13.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 3.6% | 7% | 22% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
ALIVUS LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALIVUS LIFE SCIENCES | -2.2% |
-1.4% |
-13.3% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses